Aminoglycoside resistance among isolates of nosocomial Enterobacteriaceae

Insights

Gentamicin resistance in hospital bacteria is often due to aminoglycoside-modifying enzymes. Many of these resistant Enterobacteriaceae strains showed evidence of plasmid-mediated resistance.

Area of Science:

  • Microbiology
  • Molecular biology
  • Genetics

Background:

  • Gentamicin is a crucial antibiotic for treating serious Gram-negative infections.
  • The emergence of gentamicin-resistant bacteria poses a significant threat to public health.
  • Enterobacteriaceae are common causes of hospital-acquired infections.

Purpose of the Study:

  • To investigate the mechanisms of gentamicin resistance in hospital-acquired Enterobacteriaceae.
  • To identify the prevalence of aminoglycoside-modifying enzymes in these resistant isolates.
  • To determine the potential role of plasmids in the dissemination of resistance.

Main Methods:

  • Isolation and identification of Enterobacteriaceae from clinical samples.
  • Phenotypic testing for gentamicin resistance.
  • Enzyme assays to detect aminoglycoside-modifying enzymes.
  • Conjugation experiments to assess plasmid-mediated resistance.

Main Results:

  • Fifty-seven gentamicin-resistant Enterobacteriaceae isolates were identified.
  • Fifty-one (89.5%) of these isolates produced aminoglycoside-modifying enzymes.
  • Thirty-four (66.7%) of the enzyme-producing strains exhibited plasmid-mediated resistance, confirmed by conjugation.

Conclusions:

  • Aminoglycoside-modifying enzymes are prevalent in gentamicin-resistant hospital Enterobacteriaceae.
  • Plasmids play a significant role in the spread of gentamicin resistance among these bacteria.
  • Understanding these resistance mechanisms is vital for effective antibiotic stewardship and infection control.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...